Abstract
Norepinephrine (NE) and dopamine (DA) receptor blockade differentially affected amphetamine self-administration. DA blockade (pimozide, 0.0625 to 0.5 mg/kg, or (+)-butaclamol, 0.0125 to 0.1 mg/kg) caused periods of increased rate of responding for amphetamine which were followed, in the case of higher doses, by response cessation. The response cessation produced by 0.5 mg/kg pimozide was not reversed by non-contingent amphetamine injections until well after the peak effect of the pimozide was over. When access to amphetamine injections was delayed until 4 h after animals received 0.5 mg/kg pimozide, rate of responding was elevated. Thus DA seems to be critically involved in mediation of the reinforcing effects of amphetamine. Alpha-NE blockade with phentolamine (2.5–10 mg/kg) produced dose-related decreases in responding; blockade with phenoxybenzamine (1.25–10 mg/kg) had no effect. Beta-NE blockade with l-propranolol (2.5–10 mg/kg) decreased responding, although probably not through a beta-blocking action. The effects of phentolamine and propranolol do not appear to result from attenuation of the reinforcing effects of amphetamine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Europ. J. Pharmacol. 11, 303–314 (1970)
Andén, N.-E., Strömbom, U.: Adrenergic receptor blocking agents: Effects on central noradrenaline and dopamine receptors and on motor activity. Psychopharmacologia (Berl.) 38, 91–103 (1974)
Baxter, B. L., Gluckman, M. I., Stein, L., Scerni, R. A.: Self-injection of apomorphine in the rat: Positive reinforcement by a dopamine receptor stimulant. Pharmacol. Biochem. Behav. 2, 387–391 (1974)
Blumberg, J. B., Taylor, R. E., Sulser, F.: Blockade by pimozide of a noradrenaline sensitive adenylate cyclase in the limbic forebrain: Possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics. J. Pharm. Pharmacol. 27, 125–128 (1975)
Carlsson, A.: Amphetamine and brain catecholamines. In: International Symposium on Amphetamine and Related Compounds, E. Costa and S. Garattini, eds., pp. 289–300. New York: Raven Press 1970
Cicero, T. J., Meyer, E. R., Smithloff, B. R.: Alpha adrenergic blocking agents: Antinociceptive activity and enhancement of morphine-induced analgesia. J. Pharmacol. exp. Ther. 189, 72–82 (1974)
Davis, W. M., Smith, S. G.: Effect of haloperidol on (+)-amphetamine self-administration. J. Pharm. Pharmacol. 27, 540–542 (1975)
Fouriezos, G., Wise, R. A.: Pimozide-induced extinction of intracranial self-stimulation: Response patterns rule out motor or performance deficits. Brain Res. 103, 377–380 (1976)
Goldberg, S. R., Woods, J. H., Schuster, C. R.: Nalorphine-induced changes in morphine self-administration in rhesus monkeys. J. Pharmacol. exp. Ther. 176, 464–471 (1971)
Gunne, L. M., Änggård, E., Jönsson, L. E.: Clinical trials with amphetamine-blocking drugs. Psychiat. Neurol. Neurochir. (Amst.) 75, 225–226 (1972)
Hastings, L., Stutz, R. M.: The effect of alpha- and beta-adrenergic antagonists on the self-stimulation phenomenon. Life Sci. 13, 1253–1259 (1973)
Howe, R., Shanks, R. G.: Optical isomers of propranolol. Nature (Lond.) 210, 1336–1338 (1966)
Humber, L. G., Bruderlein, F. T., Voith, K.: Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. A hypothesis on their mode of interaction with the central dopamine receptor. Molec. Pharmacol. 11, 833–840 (1975)
Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., Dresse, A., Lenaerts, F. M., Pinchard, A., Schaper, W. K. A., Van Nueten, J. M., Verbruggen, F. J.: Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine. Arzneimittel-Forsch. 18, 261–279 (1968)
Kimble, G. A.: Hilgard and Marquis' Conditioning and Learning, pp. 311–315. New York: Appleton, Century, Crofts 1961
Laverty, R., Taylor, K. M.: Propranolol uptake into the central nervous system and the effect on rat behaviour and amine metabolism. J. Pharm. Pharmacol. 20, 605–609 (1968)
Lippmann, W., Pugsley, T., Merker, J.: Effect of butaclamol and its enantiomers upon striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats. Life Sci. 16, 213–224 (1975)
Masuoka, D., Appelgren, L.-E., Hansson, E.: Autoradiographic distribution studies of adrenergic blocking agents. I. 14C-phenoxybenzamine (Bensylyt NFN), an α-receptor-type blocking agent. Acta pharmacol. (Kbh.) 25, 113–122 (1967)
Masuoka, D., Hansson, E.: Autoradiographic distribution studies of adrenergic blocking agents. II. 14C-propranolol, a β receptor-type blocker. Acta pharmacol. (Kbh.) 25, 447–455 (1967)
Miller, R. J., Horn, A. S., Iversen, L. L.: The action of neuroleptic drugs on dopamine-stimulated adenosine cyclic 3′,5′-monophosphate production in the rat neostriatum and limbic forebrain. Molec. Pharmacol. 10, 759–766 (1974)
Miller, R. J., Horn, A. S., Iversen, L. L.: Effect of butaclamol on dopamine sensitive adenylate cyclase in the rat striatum. J. Pharm. Pharmacol. 27, 212–213 (1975)
Pickens, R., Harris, W. C.: Self-administration of d-amphetamine by rats. Psychopharmacologia (Berl.) 12, 158–163 (1968)
Pickens, R., Meisch, R. A., Dougherty, J. A.: Chemical interactions in methamphetamine reinforcement. Psychol. Rep. 23, 1267–1270 (1968)
Pickens, R., Thompson, T.: Cocaine-reinforced behavior in rats: Effects of reinforcement magnitude and fixed-ratio size. J. Pharmacol. exp. Ther. 161, 122–129 (1968)
Pincus, J. H., Tucker, G. J.: Behavioral Neurology, pp. 134–135. New York: Oxford University Press 1974
Randrup, A., Munkvad, I.: Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia (Berl.) 11, 300–310 (1967)
Risner, M. E.: The possible lack of noradrenergic mechanisms in d-amphetamine (A) self-administration. Fed. Proc. 34, no. 3, p. 768, Abstract no. 3106 (1975)
Ryder, J., Schuster, C. R., Seiden, L. S.: The effects of alpha-methyl tyrosine on methamphetamine self-administration and brain catecholamine levels. Paper presented Winter Conference on Brain Research, Steamboat Springs, Colorado, Jan. 1975
Shoeman, D. W., Sirtori, C. R., Azarnoff, D. L.: Inhibition of amphetamine tolerance and metabolism by proranolol. J. Pharmacol. exp. Ther. 191, 68–71 (1974)
Soudijn, W., van Wijngaarden, I.: Localization of [3H]pimozide in the rat brain in relation to its anti-amphetamine potency. J. Pharm. Pharmacol. 24, 773–780 (1972)
Vaughan Williams, E. M.: Mode of action of beta receptor antagonists on cardiac muscle. Amer. J. Cardiol. 18, 399–405 (1966)
Voith, K., Herr, F.: The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug. Psychopharmacologia (Berl.) 42, 11–20 (1975)
Wilson, M. C., Schuster, C. R.: The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey. Psychopharmacologia (Berl.) 26, 115–126 (1972)
Wilson, M. C., Schuster, C. R.: Aminergic influences on intravenous cocaine self-administration by rhesus monkeys. Pharmacol. Biochem. Behav. 2, 563–571 (1974)
Yokel, R. A., Pickens, R.: Self-administration of optical isomers of amphetamine and methylamphetamine by rats. J. Pharmacol. exp. Ther. 187, 27–33 (1973)
Yokel, R. A., Pickens, R.: Drug level of d- and l-amphetamine during intravenous self-administration. Psychopharmacologia (Berl.) 34, 255–264 (1974)
Yokel, R. A., Wise, R. A.: Increased lever pressing for amphetamine after pimozide in rats: Implications for a dopamine theory of reward. Science 187, 547–549 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yokel, R.A., Wise, R.A. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology 48, 311–318 (1976). https://doi.org/10.1007/BF00496868
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00496868